Catalyst Wire Dossier Catalyst Wire Dossier

Ulonivirine (MK-8507)

Ulonivirine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ulonivirine (MK-8507), covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018) [Phase 1]

See pricing